立昂微(605358.SH):擬使用募集資金12.5億元對衢州金瑞泓增資、用於“年產600萬片6英寸集成電路用硅拋光片項目”
格隆匯1月10日丨立昂微(605358.SH)公佈,為推進募集資金使用計劃的實施,公司擬使用募集資金12.5億元對衢州金瑞泓增資,用於募投項目“年產600萬片6英寸集成電路用硅拋光片項目”的生產建設。
公司對衢州金瑞泓的增資價格為經坤元資產評估有限公司於2022年12月出具的《杭州立昂微電子股份有限公司擬進行增資涉及的金瑞泓科技(衢州)有限公司股東全部權益價值評估項目資產評估報吿》(坤元評報[2022]924號),所對應的衢州金瑞泓每元註冊資本的企業價值,為2.09元/每元註冊資本。此次增資完成後,衢州金瑞泓仍為公司全資子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.